Document Detail


Preliminary experience with dexmedetomidine in the treatment of cyclic vomiting syndrome.
MedLine Citation:
PMID:  12845396     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cyclic vomiting syndrome (CVS) is a chronic, recurrent disorder of unknown etiology characterized by episodes of nausea and vomiting lasting hours or days and separated by symptom-free intervals of weeks to months. Although several different therapeutic regimens have been suggested for CVS, there remains no standard, effective regimen. In many cases, management of vomiting episodes includes the use of potent sedatives that induce prolonged durations of sedation and sleep. Dexmedetomidine is an alpha(2) adrenergic agonist with an increased specificity for the alpha(2) versus the alpha(1) receptor when compared with clonidine. Several physiologic effects have been demonstrated with dexmedetomidine including sedation, anxiolysis, analgesia, and blunting of the sympathetic nervous system. We report, for the first time, successful use of dexmedetomidine to treat CVS in 3 pediatric-aged patients. Potential mechanisms for its efficacy and future potential as a therapeutic agent for CVS are discussed.
Authors:
Tariq A Khasawinah; Alejandro Ramirez; John W Berkenbosch; Joseph D Tobias
Related Documents :
25095326 - Effect of corticosteroids on orthodontic tooth movement in a rabbit model.
23766826 - Duloxetine for the treatment of post-prostatectomy stress urinary incontinence.
382156 - Domperidone in the prevention of post-operative nausea and vomiting.
23747486 - Association of sustained high plasma trough concentration of voriconazole with the inci...
25307886 - Single-center, single-blinded, randomized study of self-gripping versus sutured mesh in...
8739936 - Return to work after posterolateral fusion with transpedicular instrumentation for spon...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of therapeutics     Volume:  10     ISSN:  1075-2765     ISO Abbreviation:  Am J Ther     Publication Date:    2003 Jul-Aug
Date Detail:
Created Date:  2003-07-07     Completed Date:  2003-11-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  303-7     Citation Subset:  IM    
Affiliation:
Department of Child Health, University of Missouri, Columbia, Missouri 65212, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adrenergic alpha-Agonists / therapeutic use*
Child
Child, Preschool
Dexmedetomidine / therapeutic use*
Female
Humans
Male
Syndrome
Treatment Outcome
Vomiting / drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 113775-47-6/Dexmedetomidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Unusual electrocardiographic changes with propranolol and diltiazem overdosage: a case report.
Next Document:  Evaluation and applications of a gaseous mercuric chloride source.